Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Barberis

Showing results (71-80 of 169) with videos related to

Pageof 17
Sort By:
Cytopathology : Official Journal of the British Society for Clinical Cytology|August 28, 2023
Circulating tumour DNA testing in metastatic breast cancer: Integration with tissue testingAlberto Ranghiero, Chiara Frascarelli, Giulia Cursano, et al.
Journal of Clinical Pathology|May 6, 2020
SARS-CoV-2 detection in formalin-fixed paraffin-embedded tissue specimens from surgical resection of tongue squamous cell carcinomaElena Guerini-Rocco, Sergio Vincenzo Taormina, Davide Vacirca, et al.
European Radiology|May 10, 2015
CT Radiogenomic Characterization of EGFR, K-RAS, and ALK Mutations in Non-Small Cell Lung CancerStefania Rizzo, Francesco Petrella, Valentina Buscarino, et al.
The Oncologist|March 23, 2024
Cancers of Unknown Primary Origin: Real-World Clinical Outcomes and Genomic Analysis at the European Institute of OncologyLuca Boscolo Bielo, Carmen Belli, Edoardo Crimini, et al.
Ecancermedicalscience|February 15, 2017
Circulating and tissue biomarkers in early-stage non-small cell lung cancerCaterina Fumagalli, Fabrizio Bianchi, Paola Rafaniello Raviele, et al.
Critical Reviews in Oncology/Hematology|February 28, 2012
Vaccines in non-small cell lung cancer: rationale, combination strategies and update on clinical trialsTommaso De Pas, Monica Giovannini, Maria Rescigno, et al.
Journal of Clinical Pathology|March 15, 2018
The long tail of molecular alterations in non-small cell lung cancer: a single-institution experience of next-generation sequencing in clinical molecular diagnosticsCaterina Fumagalli, Davide Vacirca, Alessandra Rappa, et al.
Biochemistry and Biophysics Reports|September 16, 2024
<i>PIK3CA</i> mutation analysis in circulating tumor cells of patients with hormone receptor positive metastatic breast cancerElena Marino, Cristian Mauro, Elena Belloni, et al.
Expert Review of Molecular Diagnostics|July 19, 2021
The role of molecular heterogeneity targeting resistance mechanisms to lung cancer therapiesIlaria Attili, Marzia Del Re, Elena Guerini-Rocco, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 15, 2013
Recommendations for the analysis of ALK gene rearrangements in non-small-cell lung cancer: a consensus of the Italian Association of Medical Oncology and the Italian Society of Pathology and CytopathologyAntonio Marchetti, Andrea Ardizzoni, Mauro Papotti, et al.
Pageof 17

Showing results (71-80 of 169) with videos related to

Sort By:
Pageof 17
Cytopathology : Official Journal of the British Society for Clinical Cytology|August 28, 2023
Circulating tumour DNA testing in metastatic breast cancer: Integration with tissue testingAlberto Ranghiero, Chiara Frascarelli, Giulia Cursano, et al.
Journal of Clinical Pathology|May 6, 2020
SARS-CoV-2 detection in formalin-fixed paraffin-embedded tissue specimens from surgical resection of tongue squamous cell carcinomaElena Guerini-Rocco, Sergio Vincenzo Taormina, Davide Vacirca, et al.
European Radiology|May 10, 2015
CT Radiogenomic Characterization of EGFR, K-RAS, and ALK Mutations in Non-Small Cell Lung CancerStefania Rizzo, Francesco Petrella, Valentina Buscarino, et al.
The Oncologist|March 23, 2024
Cancers of Unknown Primary Origin: Real-World Clinical Outcomes and Genomic Analysis at the European Institute of OncologyLuca Boscolo Bielo, Carmen Belli, Edoardo Crimini, et al.
Ecancermedicalscience|February 15, 2017
Circulating and tissue biomarkers in early-stage non-small cell lung cancerCaterina Fumagalli, Fabrizio Bianchi, Paola Rafaniello Raviele, et al.
Critical Reviews in Oncology/Hematology|February 28, 2012
Vaccines in non-small cell lung cancer: rationale, combination strategies and update on clinical trialsTommaso De Pas, Monica Giovannini, Maria Rescigno, et al.
Journal of Clinical Pathology|March 15, 2018
The long tail of molecular alterations in non-small cell lung cancer: a single-institution experience of next-generation sequencing in clinical molecular diagnosticsCaterina Fumagalli, Davide Vacirca, Alessandra Rappa, et al.
Biochemistry and Biophysics Reports|September 16, 2024
<i>PIK3CA</i> mutation analysis in circulating tumor cells of patients with hormone receptor positive metastatic breast cancerElena Marino, Cristian Mauro, Elena Belloni, et al.
Expert Review of Molecular Diagnostics|July 19, 2021
The role of molecular heterogeneity targeting resistance mechanisms to lung cancer therapiesIlaria Attili, Marzia Del Re, Elena Guerini-Rocco, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 15, 2013
Recommendations for the analysis of ALK gene rearrangements in non-small-cell lung cancer: a consensus of the Italian Association of Medical Oncology and the Italian Society of Pathology and CytopathologyAntonio Marchetti, Andrea Ardizzoni, Mauro Papotti, et al.
Pageof 17